| Main purpose |
Broad gut health overview plus personalized nutrition and supplement recommendations. |
Gut microbiome profiling/reporting based on a stool test (recommendations may vary by program). |
| Best for |
People who want actionable, consumer-friendly guidance tied to their diet and microbiome results. |
People who want microbiome insights with a report format that may be less centered on food-dosing prescriptions. |
| Sample type |
Stool sample. |
Stool sample. |
| Analysis method |
16S DNA sequencing and Shotgun Metagenomics within its Gut Health Operating System. |
Stool-based microbiome sequencing/profiling (specific method details may depend on the exact Kaleido product). |
| What it measures |
Gut microbiome ecosystem signals used to translate into nutrition and supplement guidance. |
Microbiome composition/functional signals derived from sequencing, presented in a report format. |
| Pathogens included? |
Typically focuses on ecosystem patterns; pathogen inclusion is not emphasized in the provided positioning. |
Often includes microbial profiles; whether specific pathogens are reported depends on the test version and reporting scope. |
| Functional / microbiome balance insight |
Uses sequencing data to provide ecosystem-level balance and interpretation (including functional aspects through its OS). |
May provide functional and balance-related interpretation based on its underlying profiling approach. |
| Broad gut health overview |
Yes—designed for a broad overview understandable to consumers. |
Often includes an overview, though depth and framing can be more data/technical depending on the report. |
| Personalized recommendations |
Yes—personalized nutrition and supplement recommendations. |
May offer personalized outputs, but the degree of personalization and format can differ. |
| Nutrition guidance included |
Yes—includes food diary–driven guidance with individual food items and daily dosages. |
May include nutrition guidance depending on the program; details can vary. |
| Actionability of results |
High—translates results into specific, diet- and supplement-related next steps. |
Moderate to high—may be actionable, but can be more interpretive depending on report format. |
| Easy-to-understand report |
Designed to be easy to understand for consumers. |
Report clarity depends on the product and how it is presented; may be less consumer-first in tone. |
| Consumer-friendly vs clinician-focused |
Consumer-friendly; emphasizes translation into practical guidance. |
Can be more research/clinical adjacent in presentation depending on the offering. |
| Suitable for ongoing monitoring |
Yes—DNA sequencing allows longitudinal comparisons over time. |
Often possible for monitoring, but consistency and comparability depend on the specific method and reporting approach. |
| Turnaround time |
Not specified here; turnaround typically depends on lab scheduling and report delivery workflow. |
Not specified here; turnaround depends on the specific product and processing pipeline. |
| Price |
Not specified here. |
Not specified here. |
| Available in Europe / direct-to-consumer |
Yes—available in Europe and direct-to-consumer. |
Availability in Europe and direct-to-consumer access may vary by region/product. |
| Data privacy / EU friendliness |
Positioned for European direct-to-consumer use; details may include EU-relevant privacy considerations. |
Data privacy approach depends on the operating region and the specific data handling policy. |